We are delighted to be the exhibiting and presenting at the RAPS Euro Convergence, 13-16 May 2025 in Brussels. Purdie Pascoe’s PMCF experts, Marcus Torr, Chris Webb and Tonika Chester are attending, presenting a poster and exhibiting on Booth 37.

We are delighted to have been shortlisted for this year’s BHBIA BOBI awards, celebrating the best of business intelligence in UK healthcare. Purdie Pascoe’s submission, in collaboration with Chiesi, 'Navigating the Storm: Improving Referral Behaviours to Accelerate Fabry Disease Care' has been shortlisted in the best customer insight category.

The research world is buzzing with AI. Everywhere you look, new tools promise faster, deeper, cheaper insights. But if you peel back the marketing gloss, a more nuanced question emerges: Where does AI genuinely help—and where does it fall short?

As Head of Innovation at Purdie Pascoe, Paolo Gambetti offers his perspective about innovation in healthcare market research. He addresses a range of important points such as key drivers of innovation, how his dedicated team identifies emerging trends and technologies and the impact of AI and machine learning in the space.

PMCF experts Chris Webb and Alice Robertson recently attended and presented at the 6th Annual European Medical Device and Diagnostic Clinical Evidence Strategy Conference in Berlin. This event brought together leading clinical experts and industry professionals to discuss key issues in advancing clinical evidence.

When visiting a sensitive, emotive topic as a means to creating or refining a communications strategy, how can you optimize the true value of the voice of your customer? Watch this webcast in which Purdie Pascoe’s expert presenters, Head of MedTech, Sabera Hyderally and Director, Hazel Haskayne, show the true value of the Delphi Method.

In the third blog of our PMCF Insights Series, PMCF Manager Chris Webb, highlights why it is imperative for manufacturers to provide clinical evidence to show their devices perform as expected over its entire lifetime, as specified within the Device Regulation (EU-MDR 2017/745).

Stephen Potts and Seb Newton recently attended the 2025 UK One-Day EPHMRA meeting in London. The focus of the event was ‘Storytelling in Market Research’ and how as market researchers, our mission is to ensure the insights we deliver tell a meaningful, powerful story to a diverse range of stakeholders. This summary delves into key themes and presentations from experts in the field.

With over 25 years of experience in the industry, Hazel Haskayne offers valuable insights into pharmaceutical market research. She explores the evolution of the industry, addresses key challenges and solutions in launching new pharma products, and highlights the crucial factors to consider when selecting an agency for your market research needs.

Post-market clinical follow-up (PMCF) surveys have become a significant topic in the industry, offering a cost-effective solution for PMCF data collection. However, their effective implementation can be challenging. In this article, the PMCF experts at Purdie Pascoe focus on high-quality, case/patient-specific PMCF surveys that provide Level 4 data.

There are over 300 million people living with a rare disease across the globe, and they need help. Purdie Pascoe is dedicated to partnering with life science companies to make timely, informed decisions, and help improve the lives of those affected by rare diseases worldwide.

We are delighted to be the platinum sponsor for the 6th Annual European Medical Device and Diagnostic Clinical Evidence Strategy Conference in Berlin. PMCF Managers Chris Webb and Alice Robertson will be attending and presenting at the conference.

Watch this complimentary webcast in which PMCF Manager from Purdie Pascoe, Chris Webb, presented with Dr. Ulrich Nitsche Global Director Clinical Centre of Excellence from TÜV SÜD and Dr. Nikhil A. Khadabadi from Eclevar MedTech. These leading experts unpack critical PMCF strategies, share real-world survey experiences, and offer insights on bridging data gaps to achieve regulatory success.

In the second blog of our PMCF Insights Series, Tonika Chester and Isabel Bradshaw explore off-label usage within medical devices, from collecting off-label data in post market clinical follow up, understanding and key considerations for off-label usages to the challenges in paediatric populations and rare diseases.

Purdie Pascoe is conducting an ongoing ctDNA Cancer Monitoring US Landscape syndicated study. The first two waves are available for purchase, with a third wave set to launch soon.

A leading medical device manufacturer required Post Market Clinical Follow-Up (PMCF) data for their Class III Peripherally Inserted Central Catheter (PICC). This clinical evidence was needed to comply with PMCF data collection under the MDR

Marianne Fillion provides insights about the Precision Medicine and Diagnostics market research function at Purdie Pascoe. She delves into technological advancements, the competitive oncology landscape and why market research is so important for development and implementation in this space.

In 2024, Stephen Potts, Director at Purdie Pascoe, was diagnosed with a giant brain aneurysm that required complex surgery and a long recovery journey. Thanks to the exceptional care from his surgeons, doctors, therapists and nurses, Stephen has made significant strides in his recovery and is now enthusiastically back at work.

We are thrilled to announce that Marcus Torr, PMCF/MDR Lead at Purdie Pascoe, has been selected for the MedTech Leading Voice (MLV) list for 2025. Marcus regularly shares his expertise at industry events and on LinkedIn. We are incredibly proud to see him featured in the prestigious MLV100 list. Don't miss his future insights by following him on LinkedIn.

At Purdie Pascoe, one of our core values is ‘Supportive.’ We are dedicated to helping local communities and charities, doing our part to assist those in need. Our charity initiative group works tirelessly throughout the year to identify the best ways to support a variety of charities and local communities.